AbCellera Biologics Inc. logo

AbCellera Biologics Inc. (ABCL)

Market Closed
3 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
3. 80
+0.05
+1.33%
$
1.08B Market Cap
- P/E Ratio
0% Div Yield
1,951,500 Volume
-0.47 Eps
$ 3.75
Previous Close
Day Range
3.66 3.81
Year Range
1.89 4.08
Want to track ABCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 39 days
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
12 Aug 2025 (In 1 month)
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
5 May 2025
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
18 Feb 2025
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
4 Nov 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
31 Oct 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
6 Aug 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
1 Aug 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
13 Jun 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
20 Feb 2024
-
Cons. EPS
-
EPS
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
2 Nov 2023
-
Cons. EPS
-
EPS

ABCL Earnings Reports FAQ

What is the earnings per share (EPS) for ABCL?

The current EPS is -0.47.

When is the next earnings release date?

The next earnings release is expected to be on 2025-08-12, based on the ABCL's typical earnings announcement schedule.